Fresenius SE

First half of 2010: Preliminary Group net income substantially better than expected − Earnings outlook raised
Based on preliminary results, Fresenius Group earnings for the first half of 2010 were substantially ahead of expectations. >>>

Fresenius Medical Care enters into long-term distribution agreement in Japan and expands dialysis products business in Korea
Bad Homburg, Germany – Fresenius Medical Care AG & Co. KGaA (“the company”; Frankfurt Stock Exchange: FME / New York Stock Exchange: FMS), the world’s largest provider of dialysis products and services, has entered into a long-term, 10-year exclusive distribution agreement with Japanese-based Nikkiso Co. Ltd. for hemodialysis and peritoneal dialysis products in Japan. >>>

International forum for clever ideas: Fresenius Inventors’ Fair launches its 11th running − Registration now open
Fresenius provides an incentive to inventors for what often is a long path from their initial flash of genius to ultimately achieving a marketable product. In this endeavor, the health care group aims to promote innovative developments within all medical sectors. For the event’s 11th running, bright minds will be able to present their ingenuity during the Fresenius Inventors’ Fair. >>>

Fresenius Medical Care announces encouraging results of CALMAG study on phosphate binder OsvaRen® at the 2010 EDTA congress in Munich
Based on data from its recently completed CALMAG (CALcium acetate MAGnesium carbonate evaluation) study, Fresenius Medical Care is announcing a demonstration of the effectiveness of its combined phosphate binder OsvaRen® (calcium acetate/magnesium carbonate) in the treatment of hyperphosphatemia in hemodialysis patients. >>>

Fresenius Medical Care reaches agreement with Bumrungrad International to acquire Asia Renal Care
Fresenius Medical Care AG & Co. KGaA (“the company”), the world’s largest provider of dialysis products and services, today announced its signing of a sales and purchase agreement with Bumrungrad International Ltd. to acquire Asia Renal Care Ltd. The acquisition marks a significant expansion of the company’s activities in the field of dialysis services in the Asia-Pacific region. >>>